NAFLD / MASH (Fatty Liver Disease): The Evidence-Based Supplement Protocol

← Back to articles

Non-alcoholic fatty liver disease (NAFLD, increasingly renamed MASLD) and its inflammatory variant NASH/MASH are the most common chronic liver diseases globally. Weight loss (≥10%) is the single largest intervention. Among supplements, vitamin E has the strongest hepatology trial evidence (PIVENS), with secondary roles for omega-3, berberine, and silymarin.

Vitamin E, 800 IU Daily — Non-Diabetic NASH

The PIVENS trial (2010) in 247 non-diabetic adults with biopsy-proven NASH showed vitamin E 800 IU/day for 96 weeks produced significantly more histological improvement and resolution of NASH compared to placebo. The result has shaped AASLD guidelines, which support vitamin E in non-diabetic adults with biopsy-proven NASH. Cap at 800 IU; long-term use above this has small all-cause mortality signals. See our vitamin E NAFLD piece.

EPA + DHA Omega-3, 2–4 g Daily

Multiple meta-analyses show omega-3 reduces liver fat content (MRI-PDFF) by 5–10% relative units at 2+ g daily over 6+ months. Effect smaller than weight loss but additive. See omega-3 form piece.

Berberine, 500 mg Three Times Daily

A 2024 meta-analysis of 17 RCTs concluded berberine improves liver enzymes (ALT, AST), hepatic steatosis on imaging, and lipid profile in NAFLD. Effect comparable to first-line pharmacotherapy in some head-to-head trials. See our berberine NAFLD piece.

Silymarin (Milk Thistle), 420 mg Daily

Silymarin has small trial signals for ALT reduction in NAFLD. Effect smaller than vitamin E or berberine. Reasonable adjunct but not a primary intervention. The recent EUDRAGIT-S formulations have better bioavailability than older powder products.

Vitamin D — Repletion in Deficiency

Vitamin D deficiency is common in NAFLD cohorts. Repletion has small effects on liver enzymes in deficient adults. Treat the deficiency, not the level.

What NOT to Take

Avoid green tea extract megadoses — case reports of acute liver injury, particularly with concentrated EGCG. See our green tea hepatotoxicity piece. Skip "liver cleanse" / "liver detox" formulas — many contain herbs with hepatotoxicity risk (kava, certain Chinese herbs, comfrey). Avoid high-dose niacin in NAFLD — can worsen insulin resistance and liver enzymes. Avoid bodybuilding "anabolic support" supplements — frequent culprits in DILI case reports.

How to Run the Protocol

Confirm diagnosis with ultrasound or MRI-PDFF; transient elastography (FibroScan) for fibrosis staging. Weight loss is the primary intervention — ≥10% body weight reduction can reverse NASH histologically. Test for and treat insulin resistance / type 2 diabetes / dyslipidemia. For non-diabetic adults with biopsy-proven NASH: vitamin E 800 IU daily. For all NAFLD adults: omega-3 2 g daily + berberine 500 mg TID. Re-evaluate liver enzymes and imaging at 6 months. Hepatology referral if fibrosis is advanced. See condition page.